Sunshine Biopharma SBFM
NASDAQ SBFM
$1.13 -0.04 (-3.85%)
At close: Aug 20, 2026 · 1:32 PM UTC

Sunshine Biopharma (SBFM) Restructuring Costs (2010 - 2026)

Sunshine Biopharma's (SBFM) quarterly Restructuring Costs came in at $871608.0 in Q1 2026, down 5.86% YoY from $925878.0 in Q1 2025, and down 42.56% on a QoQ basis from $1.5 million in Q4 2025.

Sunshine Biopharma (SBFM) Restructuring Costs (2010 - 2026) Analysis & Trends

Sunshine Biopharma (SBFM) has 5 years of Restructuring Costs data on file, last reported at $871608.0 in Q1 2026.

  • Quarterly Restructuring Costs fell 5.86% year-over-year to $871608.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 23.89% YoY) and the FY2025 annual result came in at $3.9 million, up 24.26% from the prior year.
  • Restructuring Costs slipped to $871608.0 in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q4 2025 to a low of $530334.0 in Q3 2024.
  • A 4-year average of $823777.3 and a median of $806605.0 in 2025 frame the typical range for Restructuring Costs.
  • Annual changes were most pronounced in 2025 — Restructuring Costs jumped 67.48% — and 2026, when it declined 5.86%.
  • Tracing SBFM's Restructuring Costs over 4 years: stood at $720297.0 in 2023, then grew by 25.79% to $906056.0 in 2024, then jumped by 67.48% to $1.5 million in 2025, then tumbled by 42.56% to $871608.0 in 2026.
  • The last three Restructuring Costs figures came in at $871608.0 (Q1 2026), $1.5 million (Q4 2025), and $614661.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Sunshine Biopharma 1.54 Mn -12.21 Mn 2.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 762,187.00
Mar 31, 2026 871,608.00
Dec 31, 2025 1.52 Mn
Sep 30, 2025 614,661.00
Jun 30, 2025 806,605.00
Mar 31, 2025 925,878.00
Dec 31, 2024 906,056.00
Sep 30, 2024 530,334.00
Jun 30, 2024 713,245.00
Mar 31, 2024 911,211.00
Dec 31, 2023 720,297.00
Sep 30, 2023 544,215.00
Dec 31, 2010 -155,150.00